Rexulti - Otsuka Pharmaceutical Co., Ltd.
Descrição
REXULTI® (brexpiprazole)
FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia
Home Otsuka US
Brexpiprazole Final Presentation
Brexpiprazole - Mechanism of Action and Clinical Application
Agitation in Alzheimer's: Rexulti® Makes Meaningful Improvements
Otsuka and Lundbeck Announce REXULTI for Alzheimer's Agitation
FDA Approves New Schizophrenia, Depression Drug Brexpiprazole - Psychiatry Advisor
Rexulti: Package Insert
Rexulti Brexpiprazole 1mg Tablet, 30 Tablets, Treatment: Schizophrenia, Depression
Main Operating Companies, About Our Group
Otsuka Pharmaceutical Establishes Subsidiary in Singapore｜News Releases
de
por adulto (o preço varia de acordo com o tamanho do grupo)
